159 related articles for article (PubMed ID: 9618172)
1. Reconstitution of wild-type or mutant telomerase activity in telomerase-negative immortal human cells.
Wen J; Cong YS; Bacchetti S
Hum Mol Genet; 1998 Jul; 7(7):1137-41. PubMed ID: 9618172
[TBL] [Abstract][Full Text] [Related]
2. Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway.
Grobelny JV; Kulp-McEliece M; Broccoli D
Hum Mol Genet; 2001 Sep; 10(18):1953-61. PubMed ID: 11555632
[TBL] [Abstract][Full Text] [Related]
3. Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells.
Goldkorn A; Blackburn EH
Cancer Res; 2006 Jun; 66(11):5763-71. PubMed ID: 16740715
[TBL] [Abstract][Full Text] [Related]
4. Reversible conversion of immortal human cells from telomerase-positive to telomerase-negative cells.
Kumakura S; Tsutsui TW; Yagisawa J; Barrett JC; Tsutsui T
Cancer Res; 2005 Apr; 65(7):2778-86. PubMed ID: 15805278
[TBL] [Abstract][Full Text] [Related]
5. An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity.
Yi X; White DM; Aisner DL; Baur JA; Wright WE; Shay JW
Neoplasia; 2000; 2(5):433-40. PubMed ID: 11191110
[TBL] [Abstract][Full Text] [Related]
6. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids.
Perrem K; Bryan TM; Englezou A; Hackl T; Moy EL; Reddel RR
Oncogene; 1999 Jun; 18(22):3383-90. PubMed ID: 10362359
[TBL] [Abstract][Full Text] [Related]
7. Telomere maintenance by telomerase and by recombination can coexist in human cells.
Cerone MA; Londono-Vallejo JA; Bacchetti S
Hum Mol Genet; 2001 Sep; 10(18):1945-52. PubMed ID: 11555631
[TBL] [Abstract][Full Text] [Related]
8. ATM mediates cytotoxicity of a mutant telomerase RNA in human cancer cells.
Stohr BA; Blackburn EH
Cancer Res; 2008 Jul; 68(13):5309-17. PubMed ID: 18593932
[TBL] [Abstract][Full Text] [Related]
9. Immortal ALT+ human cells do not require telomerase reverse transcriptase for malignant transformation.
Sun B; Chen M; Hawks CL; Hornsby PJ
Cancer Res; 2005 Aug; 65(15):6512-5. PubMed ID: 16061628
[TBL] [Abstract][Full Text] [Related]
10. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization.
Counter CM; Hahn WC; Wei W; Caddle SD; Beijersbergen RL; Lansdorp PM; Sedivy JM; Weinberg RA
Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14723-8. PubMed ID: 9843956
[TBL] [Abstract][Full Text] [Related]
11. Mass cultured human fibroblasts overexpressing hTERT encounter a growth crisis following an extended period of proliferation.
MacKenzie KL; Franco S; May C; Sadelain M; Moore MA
Exp Cell Res; 2000 Sep; 259(2):336-50. PubMed ID: 10964501
[TBL] [Abstract][Full Text] [Related]
12. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
[TBL] [Abstract][Full Text] [Related]
13. Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA.
Li S; Rosenberg JE; Donjacour AA; Botchkina IL; Hom YK; Cunha GR; Blackburn EH
Cancer Res; 2004 Jul; 64(14):4833-40. PubMed ID: 15256453
[TBL] [Abstract][Full Text] [Related]
14. Mutant telomerase RNAs induce DNA damage and apoptosis via the TRF2-ATM pathway in telomerase-overexpressing primary fibroblasts.
Mahalingam D; Tay LL; Tan WH; Chai JH; Wang X
FEBS J; 2011 Oct; 278(19):3724-38. PubMed ID: 21824286
[TBL] [Abstract][Full Text] [Related]
15. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells.
Perrem K; Colgin LM; Neumann AA; Yeager TR; Reddel RR
Mol Cell Biol; 2001 Jun; 21(12):3862-75. PubMed ID: 11359895
[TBL] [Abstract][Full Text] [Related]
16. Transient expression of wild-type or biologically inactive telomerase allows the formation of artificial telomeres in mortal human cells.
Guiducci C; Anglana M; Wang A; Bacchetti S
Exp Cell Res; 2001 May; 265(2):304-11. PubMed ID: 11302696
[TBL] [Abstract][Full Text] [Related]
17. Telomere dynamics in cells with introduced telomerase: a rapid assay for telomerase activity on telomeres.
McChesney PA; Aisner DL; Frank BC; Wright WE; Shay JW
Mol Cell Biol Res Commun; 2000 May; 3(5):312-8. PubMed ID: 10964756
[TBL] [Abstract][Full Text] [Related]
18. Super-telomeres in transformed human fibroblasts.
Chiodi I; Belgiovine C; Zongaro S; Ricotti R; Horard B; Lossani A; Focher F; Gilson E; Giulotto E; Mondello C
Biochim Biophys Acta; 2013 Aug; 1833(8):1885-93. PubMed ID: 23570868
[TBL] [Abstract][Full Text] [Related]
19. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span.
Vaziri H; Benchimol S
Curr Biol; 1998 Feb; 8(5):279-82. PubMed ID: 9501072
[TBL] [Abstract][Full Text] [Related]
20. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
Atkinson SP; Hoare SF; Glasspool RM; Keith WN
Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
